Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Charles River Laboratories Intl. Inc (CRL) vs United States Natural Gas Fund (UNG) Price & Performance

Charles River Laboratories Intl. IncTrade
United States Natural Gas FundTrade

Price performance (Past 24H)

Key statistics

Charles River Laboratories Intl. Inc vs United States Natural Gas Fund — how do they compare? Charles River Laboratories Intl. Inc trades at $285.21 (market cap $13.46B), while United States Natural Gas Fund trades at $10.22. The key difference: Charles River Laboratories Intl. Inc is trading nearer its 52-week high, United States Natural Gas Fund nearer its low. Which is the better fit depends on your goals.

CRLUNG
Market Cap
$13.46B
Sector
HealthCommodities - Energy
52-Week High
$282.00$16.90
52-Week Low
$145.57$9.63
Enterprise Value
$16.30B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Charles River Laboratories Intl. Inc

Charles River Laboratories (CRL) trades at $277.00, up 3.56% on the day and near its 52-week high of $277.07, reflecting strong bullish momentum. The stock exhibits positive technical signals with moving averages indicating an uptrend, though oscillators suggest overbought conditions. Fundamentally, the company reported Q2 2026 EPS of $3.02, beating estimates, and raised full-year guidance, yet faces profitability challenges with a negative net income margin of -5.96% and elevated valuation ratios like a P/E of 684.85. Recent news highlights improved biotech demand and institutional buying interest.

The outlook for CRL is cautiously optimistic, driven by earnings beats and raised guidance, but high valuation and weak profitability pose risks. Investment opportunity lies in sustained demand for drug development services, while risks include margin pressure, debt levels, and sensitivity to biotech funding cycles. The stock's proximity to all-time highs warrants monitoring for pullbacks.

United States Natural Gas Fund

UNG, tracking U.S. natural gas futures, trades at $10.24 with a 0.99% daily gain. Technical indicators show a bearish trend with moving averages signaling sell pressure, while oscillators remain neutral. Recent news highlights steady natural gas prices amid weather-driven demand shifts and geopolitical tensions. The fund lacks traditional company fundamentals as it is an ETF, with financial ratios unavailable.

The outlook is cautious due to bearish technicals and volatile commodity exposure. Opportunities exist if natural gas demand surges from weather or LNG exports, but risks include price swings from storage levels and production changes. Investors should weigh this as a speculative play on energy markets.

Returns comparison

Trailing returns across standard periods

About Charles River Laboratories Intl. Inc

Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.

Read more on CRL

About United States Natural Gas Fund

UNG is a commodity ETF that tracks the daily price movements of natural gas futures. It primarily invests in front-month contracts at the Henry Hub, making it a highly volatile tool for short-term trading rather than long-term holding due to contango and roll costs.

Read more on UNG